세계의 가상현실 노출 치료 시장 : 예측(2023-2028년)

The virtual reality exposure therapy market is expected to grow at a CAGR of 38.53% over the forecast period.

The virtual reality exposure therapy (VRET) market is a game-changing section of mental health therapy that uses cutting-edge virtual reality (VR) technology to treat a variety of anxiety disorders and phobias. VRET provides a secure and controlled setting in which patients may address their anxieties by gradually and repeatedly exposing themselves to anxiety-inducing stimuli. VRET simulates real-life settings by immersing patients in virtual environments, allowing therapists to guide clients through therapy sessions in a controlled and supervised way. This immersive and participatory method has been shown to be beneficial in treating illnesses such as PTSD, social anxiety, and particular phobias. As mental health professionals and patients embrace this novel and promising therapy modality, the virtual reality exposure therapy market is likely to rise significantly.

Advancements in Virtual Reality Technology Enhances the Virtual Reality Exposure Therapy Market Growth.

Virtual reality (VR) technological advancements have dramatically improved the virtual reality exposure therapy (VRET) experience, propelling innovation in mental health treatment. VR technology has advanced to provide very immersive and realistic experiences, giving patients a greater sensation of presence and involvement. More lifelike and dynamic virtual worlds are made possible by improved resolution, graphics, and motion tracking capabilities. These advances enable therapists to build customized settings that closely resemble real-life conditions, allowing for individualized exposure treatment. Furthermore, the development of user-friendly and accessible VR equipment has extended VRET's accessibility to a larger patient group, making it more accessible in therapeutic settings. As VR technology advances, it has the potential to transform the area of mental health care by delivering more effective and promising therapeutic methods.

Growing Awareness and Adoption of Non-Invasive Therapies in Virtual Reality Exposure Therapy Market.

The increased acceptance and understanding of non-invasive therapies have considerably aided the growth of the virtual reality exposure therapy (VRET) market. Non-invasive treatments have gained popularity as people seek alternative treatment alternatives owing to their potential to give excellent outcomes without the need for intrusive procedures or drugs. VRET is in line with this trend, providing a non-invasive way to treat anxiety disorders and phobias via immersive virtual experiences. The demand for VRET has risen as mental health professionals and patients become more aware of the benefits of non-invasive therapy. Because of its safety, personalised approach, and capacity to minimise harmful negative effects, the treatment has become a popular option in modern mental health care.

Personalized and Targeted Treatment Approaches Boost the Virtual Reality Exposure Therapy Market Size.

Personalised and tailored treatment techniques are propelling the virtual reality exposure therapy (VRET) market forward. VRET enables therapists to design customised virtual situations based on particular patients' fears and anxieties. VRET delivers a highly personalised therapy approach by personalising the virtual experiences, ensuring that patients confront their triggers in a controlled and supportive setting. This level of customisation allows therapists to address the individual requirements and obstacles of each patient, resulting in more effective and successful outcomes. The capacity to concentrate and focus on specific fears improves the efficacy of the therapy, making VRET a helpful tool in treating numerous anxiety disorders and phobias with more accuracy and patient satisfaction.

North America is the Market Leader in the Virtual Reality Exposure Therapy Market.

North America is the market leader in the virtual reality exposure therapy (VRET) market. Several reasons contribute to the region's leadership, including modern healthcare infrastructure, a high prevalence of mental health issues, and early use of virtual reality technology in treatment settings. Several prominent firms and startups provide VRET solutions in North America, supporting innovation and driving virtual reality exposure therapy market growth. Furthermore, the region's supportive regulatory framework and growing knowledge of the benefits of VRET for anxiety and phobia therapy have boosted its market presence. As VRET gaining traction across the world, North America continues to be at the forefront of its adoption and development.

Integration of Virtual Reality Exposure Therapy in Clinical Practice in Virtual Reality Exposure Therapy Market.

Virtual reality exposure therapy (VRET) integration in clinical practice has transformed mental health therapy. VRET is smoothly integrated by therapists as a beneficial tool to supplement standard therapeutic approaches. In a controlled context, the use of immersive virtual worlds allows for systematic desensitisation to anxiety-inducing stimuli. VRET allows therapists to give exposure treatment more swiftly while precisely monitoring patients' progress. Patients confront their concerns in a secure environment by simulating real-life circumstances, resulting in fewer avoidance behaviours and improved coping methods. Furthermore, VRET may be modified to treat a wide range of anxiety disorders and phobias, increasing its adaptability and efficacy in therapeutic settings. VRET's revolutionary influence on mental health care continues to grow as more mental health practitioners incorporate it, resulting in greater treatment results for patients.

Key Developments:

• In May 2022, Oxford VR, a virtual reality pioneer, announced the completion of a $12.5 million Series A fundraising round, the largest investment funding for VR therapy in the UK and Europe.
• In December 2022, BehaVR and OxfordVR, two virtual reality mental and behavioural health companies, announced their merger today, backed by a $13 million Series B round led by Optum Ventures and Oxford Science Enterprises, with participation from Confluent Health, Accenture Ventures, Chrysalis Ventures, and Thornton Capital.

Company Products:

• Virtual Reality Analytics Platform: CognitiveVR will most likely provide a full analytics platform that allows mental health doctors and researchers to collect and analyse data from VRET sessions. During exposure therapy, this platform enables the monitoring of patient responses, behaviours, and progress.
• Immersive Virtual Environments: Oxford VR is anticipated to provide a library of realistic virtual settings that mirror real-life scenarios, allowing patients to confront and gradually overcome specific phobias and anxieties.
• Virtual Reality Hardware: The business may provide a suite of virtual reality technology, like as headsets and motion-tracking controllers, to provide patients with a highly realistic and engaging VRET experience.
• LimbixVR App: Limbix is anticipated to provide a user-friendly and engaging virtual reality software for exposure treatment. The app might offer a library of immersive and configurable scenarios that mirror real-life circumstances, allowing therapists to construct customised exposure sessions for patients.

Segmentation:

By Component

• Hardware
• Software

By Application

• Anxiety Disorders
• Post-Traumatic Stress Disorder (Ptsd)
• Phobias And Specific Fears
• Panic Disorder
• Obsessive-Compulsive Disorder (Ocd)
• Others

By Type

• Monitoring And Health Tracking
• Disease Management
• Remote Consultation And Telemedicine
• Medication Adherence
• Fitness And Nutrition
• Women's Health
• Others

By End-User

• Hospitals And Clinics
• Mental Health Centers
• Research Institutes
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Taiwan
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Sources
• 2.3. Research Design

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porters Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY COMPONENT

• 5.1. Introduction
• 5.2. HARDWARE
• 5.3. SOFTWARE

6. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY APPLICATION

• 6.1. Introduction
• 6.2. ANXIETY DISORDERS
• 6.3. POST-TRAUMATIC STRESS DISORDER (PTSD)
• 6.4. PHOBIAS AND SPECIFIC FEARS
• 6.5. PANIC DISORDER
• 6.6. OBSESSIVE-COMPULSIVE DISORDER (OCD)
• 6.7. OTHERS

7. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY TYPE

• 7.1. Introduction
• 7.2. MONITORING AND HEALTH TRACKING
• 7.3. DISEASE MANAGEMENT
• 7.4. REMOTE CONSULTATION AND TELEMEDICINE
• 7.5. MEDICATION ADHERENCE
• 7.6. FITNESS AND NUTRITION
• 7.7. WOMEN'S HEALTH
• 7.8. OTHERS

8. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY END-USER

• 8.1. Introduction
• 8.2. HOSPITALS AND CLINICS
• 8.3. MENTAL HEALTH CENTERS
• 8.4. RESEARCH INSTITUTES
• 8.5. OTHERS

9. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. United States
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. United Kingdom
  • 9.4.2. Germany
  • 9.4.3. France
  • 9.4.4. Italy
  • 9.4.5. Spain
  • 9.4.6. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. Japan
  • 9.6.2. China
  • 9.6.3. India
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Taiwan
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Emerging Players and Market Lucrativeness
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

• 11.1. VIRTUALLY BETTER, INC.
• 11.2. LIMBIX INC.
• 11.3. PSIOUS
• 11.4. OXFORD VR
• 11.5. APPLIEDVR, INC.
• 11.6. VIRTUAL REALITY MEDICAL CENTER
• 11.7. VIRTUAL REHAB
• 11.8. BRAVEMIND (DEVELOPED BY USC INSTITUTE FOR CREATIVE TECHNOLOGIES)
• 11.9. XRHEALTH (FORMERLY KNOWN AS VRHEALTH)
• 11.10. COGNIFIT